Internal Medicine, Clinical Cardiatric Electrophysiology · Mobile, AL
NPI
1891742821
Since 2006
Specialty
Internal Medicine, Clinical Cardiatric Electrophysiology
Code 207RC0001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
600 Providence Park Dr E
Mobile, AL, 36695
Phone (251) 634-1544
Groups this clinician bills Medicare through
Medicare paid, 2024
$399K
4,430 services
Medicare patients, 2024
657
Average age 76
Drug cost, 2024
$2.2M
9,243 prescriptions
Company payments, 2025
$2,397
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephanie D Grosz was code 99214 (office e&m - established), 955 times for 408 patients. In total Stephanie D Grosz billed 4,430 services in 82 codes, and Medicare paid $399K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-02-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 955 | 408 | $79.15 | $76K |
| 93000 Electrocardiogram | Office | 555 | 347 | $8.83 | $4,901 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 372 | 93 | $5.56 | $2,069 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 237 | 199 | $11.24 | $2,665 |
| 93306 Echocardiography (TTE/TEE) | Office | 219 | 217 | $112.84 | $25K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 192 | 95 | $214.18 | $41K |
| 93296 External Electrocardiographic Monitoring | Office | 156 | 90 | $12.17 | $1,899 |
| 99215 Office E&M - Established | Office | 118 | 94 | $101.50 | $12K |
| 93294 External Electrocardiographic Monitoring | Office | 113 | 65 | $18.14 | $2,050 |
| 99152 Anesthesia | Facility | 105 | 52 | $8.23 | $864 |
| 93015 Electrocardiogram | Office | 98 | 98 | $43.85 | $4,298 |
| 85610 Clinical Chemistry | Office | 91 | 15 | $4.20 | $382 |
| 99211 Office E&M - Established | Office | 81 | 13 | $14.24 | $1,153 |
| 78431 Myocardial Perfusion Scan | Office | 77 | 76 | $1,507.43 | $116K |
| 93280 External Electrocardiographic Monitoring | Office | 69 | 46 | $46.89 | $3,236 |
By year: 2022 $484K for 4,875 services; 2023 $611K for 4,963 services; 2024 $399K for 4,430 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 91 | 15 | $4.20 | $382 |
Medicare prescription drug claims, 2024
In 2024, the drug Stephanie D Grosz prescribed most often to Medicare patients was Entresto (Sacubitril/Valsartan), with 573 prescriptions and refills. In total Stephanie D Grosz wrote 9,243 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Entresto Sacubitril/Valsartan | 573 | 986 | 139 | $607K |
| Atorvastatin Calcium Generic | 558 | 1,625 | 187 | $6,837 |
| Carvedilol Generic | 554 | 1,508 | 174 | $4,937 |
| Xarelto Rivaroxaban | 520 | 973 | 114 | $538K |
| Amlodipine Besylate Generic | 502 | 1,458 | 186 | $2,911 |
| Bisoprolol Fumarate Generic | 489 | 1,372 | 164 | $21K |
| Eliquis Apixaban | 449 | 807 | 115 | $470K |
| Potassium Chloride Generic | 315 | 859 | 120 | $6,843 |
| Metoprolol Succinate Generic | 290 | 819 | 98 | $7,109 |
| Amiodarone Hcl Generic | 283 | 786 | 106 | $8,079 |
| Clopidogrel Clopidogrel Bisulfate | 268 | 719 | 99 | $3,162 |
| Torsemide Generic | 264 | 678 | 86 | $4,920 |
| Furosemide Generic | 242 | 654 | 94 | $1,486 |
| Losartan Potassium Generic | 217 | 644 | 88 | $3,171 |
| Rosuvastatin Calcium Generic | 210 | 620 | 78 | $3,485 |
Brand drugs: 2,016 claims; generic drugs: 7,227 claims; opioid claims: 29.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephanie D Grosz $2,397 ($2,397 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbott Laboratories with $1,617.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 11 | $1,617 |
| Biosense Webster, Inc. JNJ | 3 | $153 |
| Medtronic, Inc. MDT | 2 | $137 |
| Novo Nordisk Inc NVO | 5 | $105 |
| Merck Sharp & Dohme LLC MRK | 4 | $65.85 |
| Philips North America LLC PHG | 2 | $64.57 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $49.11 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $45.63 |
| Cardiva Medical, Inc. | 2 | $37.61 |
| Scpharmaceuticals Inc. SCPH | 2 | $36.92 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.